Norethindrone

Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.

Cross Reference

Introduction

To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Norethindrone?

Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Norethindrone

MeSH term MeSH ID Detail
Pancreatic Neoplasms D010190 77 associated lipids
Arteriosclerosis D001161 86 associated lipids
Body Weight D001835 333 associated lipids
Total 3

PubChem Associated disorders and diseases

What pathways are associated with Norethindrone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Norethindrone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Norethindrone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Norethindrone?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Norethindrone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Norethindrone?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Norethindrone

Download all related citations
Per page 10 20 50 100 | Total 3869
Authors Title Published Journal PubMed Link
Eisenstadt HB Abnormal liver function and synthetic estrogens. 1965 JAMA pmid:5898078
Schedl HP Absorption of steroid hormones from the human small intestine. 1965 J. Clin. Endocrinol. Metab. pmid:5841301
STOLL BA et al. ORAL CONTRACEPTIVES AND LIVER DAMAGE. 1965 Br Med J pmid:14245215
EHTISHAMUDDIN M VERTEBRAL-ARTERY THROMBOSIS AND ORAL CONTRACEPTIVES. 1965 Br Med J pmid:14257414
PAULSEN CA PROGESTIN METABOLISM: SPECIAL REFERENCE TO ESTROGENIC PATHWAYS. 1965 Metab. Clin. Exp. pmid:14261416
RICE WRAY E et al. CLINICAL EVALUATION OF NORETHINDRONE ACETATE IN FERTILITY CONTROL. 1965 Am. J. Obstet. Gynecol. pmid:14329159
MARGULIS RR et al. PROGESTATIONAL AGENTS AND BLOOD COAGULATION. 1965 Am. J. Obstet. Gynecol. pmid:14336644
DELORIMIER AA et al. METHYLTESTOSTERONE, RELATED STEROIDS, AND LIVER FUNCTION. 1965 Arch. Intern. Med. pmid:14315662
Geller S [Biochemical study of the blockage of ovarian function by norethisterone acetate]. 1965 Pathol Biol pmid:5320280
LEACH RB and MARGULIS RR INHIBITION OF ADRENOCORTICAL RESPONSIVENESS DURING PROGESTIN THERAPY. 1965 Am. J. Obstet. Gynecol. pmid:14310030
Hulka JF et al. Effect of synthetic progestational agents on allograft rejection and circulating antibody production. 1965 Endocrinology pmid:5320849
LARSSON-COHN U and STENRAM U JAUNDICE DURING TREATMENT WITH ORAL CONTRACEPTIVE AGENTS: REPORT OF TWO CASES. 1965 JAMA pmid:14326711
LARSSON-COHN U ORAL CONTRACEPTION AND SERUM PROTEIN-BOUND IODINE. 1965 Lancet pmid:14247890
Mauvais-Jarvis P et al. [In vivo studies on metabolism of androgens following administration of steroid inhibitors of ovulation. 1. Changes in the secretion of androgens and excretion of their metabolites in normal subjects and women with the Stein-Leventhal syndrome]. 1965 Acta Endocrinol. pmid:5897059
Dhom G et al. [The effect of an ovulation inhibitor (17-alpha-ethinyl-19-nortestosterone) on gonadotropic cells of the rat hypophysis]. 1965 Beitr Pathol Anat pmid:5851329
Ueda Y et al. [Clinical results and problems of oral contraceptives, a combination of norethindrone and mestranol (2)]. 1965 Saishin Igaku pmid:5869520
Illis L et al. Oral contraceptives and cerebral arterial occlusion. 1965 Br Med J pmid:5833621
Pochi PE and Strauss JS Lack of androgen effect on human sebaceous glands with low-dosage norethindrone. 1965 Am. J. Obstet. Gynecol. pmid:5843402
BRYANS FE ORAL CONTRACEPTION. 1965 Can Med Assoc J pmid:14270213
McCarthy JD Influence of two contraceptives on induction of mammary cancer in rats. 1965 Am. J. Surg. pmid:5862377
Greenwald GS Anti-ovulatory potency of various steroids, determined by single injection into female hamsters. 1965 J. Endocrinol. pmid:4284302
Raeside JI Urinary excretion of dehydroepiandrosterone and oestrogens by the boar. 1965 Acta Endocrinol. pmid:4284818
FRANCIS WG and DALZEIL D ACCIDENTAL INGESTION OF ORAL CONTRACEPTIVES BY CHILDREN. 1965 Can Med Assoc J pmid:14232198
BAINES GF JAUNDICE IN A PATIENT TAKING NORETHISTERONE COMPOUND TABLETS. 1965 Lancet pmid:14234193
Loraine JA et al. Hormone excretion patterns during and ater the long-term administration of oral contraceptives. 1965 Acta Endocrinol. pmid:5897062
Kostant GH Progestin-estrogen combinations in management of acne. 1965 J Med Soc N J pmid:4220687
Porto JA and Abreu J [Treatment of acne in male patients with anovulatory compounds]. 1965 Hospital (Rio J) pmid:4221295
BELL ET and LORAINE JA TIME OF OVULATION IN RELATION TO CYCLE LENGTH. 1965 Lancet pmid:14289439
RAUSCHER H and LEEB H [EXAMINATION OF THE EFFECT OF ETHINYL NORTESTOSTERONE ACETATE ON THE INTERNAL GENITALIA IN WOMEN]. 1965 Bibl Gynaecol pmid:14238629
CRIST RD et al. PLACENTAL TRANSFER OF SYNTHETIC PROGESTINS. 1965 Obstet Gynecol pmid:14242556
CASPARY EA and PEBERDY M ORAL CONTRACEPTION AND BLOOD-PLATELET ADHESIVENESS. 1965 Lancet pmid:14287318
PECK SJ EVALUATION OF LOW DOSE ORAL CONTRACEPTIVE. 1965 J Fla Med Assoc pmid:14257646
HOUGIE C et al. EFFECT OF A PROGESTIN-ESTROGEN ORAL CONTRACEPTIVE ON BLOOD CLOTTING FACTORS. 1965 Metab. Clin. Exp. pmid:14261425
RICE WRAY E et al. THE ACCEPTABILITY OF ORAL PROGESTINS IN FERTILITY CONTROL. 1965 Metab. Clin. Exp. pmid:14261432
PLANT GH PRODUCTION AND QUALITY CONTROL OF AN ORAL CONTRACEPTIVE. 1965 Med. J. Aust. pmid:14265218
BOARD JA CLINICAL EVALUATION OF THE ORAL CONTRACEPTIVE USE OF NORETHINDRONE 5 MG. PLUS MESTRANOL 0.075 MG. 1965 Can Med Assoc J pmid:14272499
HARTVEIT F COMPLICATIONS OF ORAL CONTRACEPTION. 1965 Br Med J pmid:14213119
RIMINGTON C and DEMATTEIS F ORAL CONTRACEPTIVES AND ACUTE INTERMITTENT PORPHYRIA. 1965 Lancet pmid:14238081
ROLAND M et al. CLASSIFICATION OF ENDOMETRIAL RESPONSE TO SYNTHETIC PROGESTOGEN-ESTROGEN COMPOUNDS. 1964 Mar-Apr Fertil. Steril. pmid:14126768
MOYER DL et al. VAGINAL CYTOHORMONAL EFFECTS OF LONG-TERM CYCLIC ADMINISTRATION OF SYNTHETIC PROGESTINS. 1964 Mar-Apr Fertil. Steril. pmid:14126769
VOKAER R [PROGESTERONE AND SYNTHETIC PROGESTATIVE AGENTS]. 1964 Mar-Apr Ann. Endocrinol. (Paris) pmid:14163467
PALMER R CELIOSCOPIC STUDY OF WOMEN TREATED WITH CYCLIC NORETHISTERONE FOR ENDOMETRIOSIS. 1964 Jan-Mar Int. J. Fertil. pmid:14106243
SCHOCKAERT JA and MOULINASSE R CLINICAL OBSERVATIONS WITH PROLONGED CONTINUOUS ADMINSTRATION OF NORETHISTERONE ACETATE. 1964 Jan-Mar Int. J. Fertil. pmid:14106244
LORAINE JA THE EFFECT OF ANTI-OVULATORY COMPOUNDS ON HORMONE EXCRETION. 1964 Jan-Mar Int. J. Fertil. pmid:14106250
GOISIS M EFFECTS OF PROGESTATIONAL STEROIDS ON THE MORPHOLOGY AND FUNCTION OF ANTERIOR PITUITARY AND OVARIES IN THE BABOON. 1964 Jan-Mar Int. J. Fertil. pmid:14106252
BUCHHOLZ R et al. THE INFLUENCE OF GESTAGENS ON THE URINARY EXCRETION OF PITUITARY GONADOTROPINS, ESTROGENS, AND PREGNANEDIOL IN WOMEN IN THE POSTMENOPAUSE AND DURING THE MENSTRUAL CYCLE. 1964 Jan-Mar Int. J. Fertil. pmid:14106262
ANDREWS WC and ANDREWS MC REDUCTION OF SIDE EFFECTS FROM OVULATION SUPPRESSION BY THE USE OF NEWER PROGESTIN COMBINATIONS. 1964 Jan-Feb Fertil. Steril. pmid:14105096
KEMPERS RD ORAL CONTRACEPTION. 1964 GP pmid:14104219
KISTNER RW STEROID COMPOUNDS WITH PROGESTATIONAL ACTIVITY. 1964 Postgrad Med pmid:14129897
CROCKER KM and STITT WD OVULATION INHIBITORS. 1964 Can Med Assoc J pmid:14130491
BUXTON CL and KASE N HORMONAL CONTROL OF CONCEPTION. 1964 Practitioner pmid:14130829
KRUEGER HG and SANDERS JH NORETHINDRONE AND MESTRANOL. EXPERIENCE IN PRIVATE PRACTICE WITH A NEW LOW-DOSAGE ORAL CONTRACEPTIVE. 1964 Ohio State Med J pmid:14134747
SCOVILLE AB ORAL CONTRACEPTION. 1964 J Tenn Med Assoc pmid:14135604
DEHAEN P THERAPEUTIC RESEARCH IN REVIEW. 1964 Med Sci pmid:14143127
FLOWERS CE THE USE OF PROGESTINS IN OBSTETRICS AND GYNECOLOGY. 1964 N C Med J pmid:14143212
SATTERTHWAITE AP A COMPARATIVE STUDY OF LOW DOSAGE ORAL CONTRACEPTIVES. 1964 Appl Ther pmid:14144491
PETERSON DL et al. STEROID-INDUCED BLOCK OF OVARIAN COMPENSATORY HYPERTROPHY IN HEMICASTRATED FEMALE RATS. 1964 J. Endocrinol. pmid:14200359
WOOD JE and GOODRICH SM DILATION OF THE VEINS WITH PREGNANCY OR WITH ORAL CONTRACEPTIVE THERAPY. 1964 Trans. Am. Clin. Climatol. Assoc. pmid:14301914
Strauss JS and Pochi PE Effect of cyclic progestin-estrogen therapy on sebum and acne in women. 1964 JAMA pmid:12254865
PAROS NL SIDE-EFFECTS OF ORAL CONTRACEPTIVES. 1964 Br Med J pmid:14088325
TYLER ET CURRENT STATUS OF ORAL CONTRACEPTION. 1964 JAMA pmid:14089002
CROOKE AC et al. PREGNANCY IN WOMEN WITH SECONDARY AMENORRHOEA TREATED WITH HUMAN GONADOTROPHINS. 1964 Lancet pmid:14074497
DUNCAN GW et al. EFFECT OF 7-ALPHA-METHYLATION ON BIOLOGICAL ACTIVITIES ON NORETHINDRONE. 1964 Proc. Soc. Exp. Biol. Med. pmid:14197511
WHARTON LR and SCOTT RB EXPERIMENTAL PRODUCTION OF GENITAL LESIONS WITH NORETHINDRONE. 1964 Am. J. Obstet. Gynecol. pmid:14198966
BEER MA CONTRACEPTIVE EFFICACY OF NORETHINDRONE WITH MESTRANOL: NEW LOW DOSAGE FORM. 1964 J Med Soc N J pmid:14199356
DESAULLES PA and KRAEHENBUEHL C COMPARISON OF THE ANTI-FERTILITY AND SEX HORMONAL ACTIVITIES OF SEX HORMONES AND THEIR DERIVATIVES. 1964 Acta Endocrinol. pmid:14225842
TREICHLER HP and HORVATH PN ERYTHEMA MULTIFORME EXUDATIVUM (STEVENS-JOHNSON SYNDROME) IN EARLY PREGNANCY: REPORT OF A CASE. 1964 Obstet Gynecol pmid:14199548
MEARS E CLINICAL EXPERIENCE IN THE USE OF ORAL CONTRACEPTIVES. 1964 Proc. R. Soc. Med. pmid:14130873
MATTHEWS JG CONTROLLED RHYTHM: A PRELIMINARY REPORT. 1964 J Am Osteopath Assoc pmid:14199890
TAYMOR ML EFFECT OF SYNTHETIC PROGESTINS ON PITUITARY GONADOTROPHIN EXCRETION. 1964 J. Clin. Endocrinol. Metab. pmid:14202759
DAUWE O [ARTIFICIAL ARREST OF OVULATION]. 1964 Scalpel (Brux) pmid:14203004
BEHRMAN SJ NORETHINDRONE, 2 MG.: AN EVALUATION. 1964 Obstet Gynecol pmid:14211016
PRAKASH S and SCULLY RE SARCOMA-LIKE PSEUDOPREGNANCY. CHANGES IN UTERINE LEIOMYOMAS. REPORT OF A CASE RESULTING FROM PROLONGED NORETHINDRONE THERAPY. 1964 Obstet Gynecol pmid:14211017
WATTS GF et al. PREGNANCY FOLLOWING WITHDRAWAL FROM ORAL CONTRACEPTIVE MEASURES. 1964 Am. J. Obstet. Gynecol. pmid:14212800
FLORSHEIM WH and FAIRCLOTH MA EFFECTS OF ORAL OVULATION INHIBITORS ON SERUM PROTEIN-BOUND IODINE AND THYROXINE BINDING PROTEINS. 1964 Proc. Soc. Exp. Biol. Med. pmid:14219959
ROVINSKY JJ CLINICAL EFFECTIVENESS OF A LOW-DOSE PROGESTIN-ESTROGEN COMBINATION. 1964 Obstet Gynecol pmid:14168244
NEWLAND DO et al. EFFECTIVENESS OF A LOW-DOSE ORAL CONTRACEPTIVE TABLET. 1964 Obstet Gynecol pmid:14168258
ANCLA M and BELAISCH J [ACTION OF NORESTHISTERONE ON CERTAIN INTRANUCLEAR CORPUSCLES PRESENT IN THE GLANDULAR EPITHELIUM OF HUMAN ENDOMETRIUM. STUDY BY ELECTRON MICROSCOPE]. 1964 Rev Fr Etud Clin Biol pmid:14172581
MAMOU H et al. [RECURRENT PAROTITIS TREATED BY 19-NORSTEROIDS]. 1964 Sem Hop pmid:14174424
HENZL M et al. [PROLIFERATIVE EFFECT OF 17-ALPHA-ETHINYL-19-NORTESTOSTERONE]. 1964 Arch Gynakol pmid:14174811
SHELLEY WB and RESNIK SS METHYSERGIDE INDUCED DEGRANULATION OF THE BASOPHIL LEUKOCYTE IN MAN. 1964 J. Invest. Dermatol. pmid:14234855
SAWASAKI C et al. [ON THE EFFECTS OF LONG-TERM ORAL ADMINISTRATION OF NORETHISTERONE ON LIVER FUNCTION]. 1964 Sanfujinka Chiryo pmid:14237097
ROGERS J MENSTRUAL DISORDERS. 1964 N. Engl. J. Med. pmid:14092181
GOLDZIEHER JW NEWER DRUGS IN ORAL CONTRACEPTION. 1964 Med. Clin. North Am. pmid:14149247
POLETTI H et al. [EARLY CHANGES IN BASOPHIL CELLS OF THE PITUITARY, IN THE WHITE RAT, INDUCED BY NORETHISTERONE ACETATE]. 1964 An Fac Med Univ Repub Montev Urug pmid:14268376
FRANCE ES and PINCUS G BIOLOGICALLY ACTIVE SUBSTANCES AFFECTING GONADOTROPHIN-INDUCED OVULATION IN IMMATURE RATS. 1964 Endocrinology pmid:14235403
ZILKHA KJ CEREBROVASCULAR ACCIDENTS AND ORAL CONTRACEPTION. 1964 Br Med J pmid:14198735
JUNKMANN K [HORMONAL CONTRACEPTION]. 1964 Mitt Dtsch Pharm Ges Pharm Ges DDR pmid:14247999
BOARD JA and BORLAND DS ENDOMETRIAL EFFECTS OF MESTRANOL-NORETHINDRONE SEQUENTIAL THERAPY FOR ORAL CONTRACEPTION. 1964 Obstet Gynecol pmid:14227594
TYLER ET CURRENT STATUS OF LOS ANGELES ORAL CONTRACEPTION STUDIES. 1964 Appl Ther pmid:14167338
PALVA IP and MUSTALA OO ORAL CONTRACEPTIVES AND LIVER DAMAGE. 1964 Br Med J pmid:14171108
CAMERON WJ and WARREN JC NORETHINDRONE MESTRANOL AS A THERAPEUTIC AGENT. 1964 Appl Ther pmid:14167339
SHEARMAN RP OVARIAN FUNCTION DURING AND AFTER LONG-TERM TREATMENT WITH OVULATION INHIBITORS. 1964 Lancet pmid:14172349
LAPOINTE R THERAPY OF CYCLIC DYSFUNCTION. 1964 Appl Ther pmid:14167340
CROCKER KM MENOMETRORRHAGIA: A NEW APPROACH TO THERAPY. 1964 Appl Ther pmid:14167341
BURT RK MENOPAUSAL BLEEDING. 1964 Appl Ther pmid:14167342
TOMPKINS MG PROGESTINS AND THE UTERUS. 1964 Appl Ther pmid:14167343
SMITH GG and DICKINSON JH THE THERAPEUTIC POTENTIAL OF NORETHINDRONE WITH MESTRANOL IN FUNCTIONAL BLEEDING. 1964 Appl Ther pmid:14167344
MATTHEWS JG ORTHO-NOVUM 2 MG. IN CONCEPTION CONTROL. 1964 J Am Osteopath Assoc pmid:14181590
CHARLES D IATROGENIC ENDOMETRIAL PATTERNS. 1964 J. Clin. Pathol. pmid:14159445